|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion, net | |||||
| Provision for credit losses | |||||
| Deferred income tax expense | |||||
| Income from accretion of discount associated with Loans at amortized cost, net | |||||
| Income from merchant fees associated with Loans at fair value | |||||
| Changes in fair value of loans | |||||
| Change in bank partner fees carried at fair value | |||||
| Amortization of debt issuance costs | |||||
| Stock-based compensation costs | |||||
| Changes in assets and liabilities: | |||||
| Decrease in lease liability | |||||
| Increase in uncollected fees on earning assets | |||||
| Increase (decrease) in income tax liability | |||||
| Increase in accounts payable and accrued expenses | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Proceeds from recoveries on charged off receivables | |||||
| Investments in earning assets | |||||
| Proceeds from earning assets | |||||
| Acquisition of Mercury (net of cash acquired) | |||||
| Purchases and development of property | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Noncontrolling interests contributions | |||||
| Noncontrolling interests distributions | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of Series B preferred stock, net of issuance costs | |||||
| Preferred stock and preferred unit dividends | |||||
| Proceeds from exercise of stock options | |||||
| Purchase and retirement of outstanding stock and preferred units | |||||
| Proceeds from issuance of Senior notes, net of issuance costs | |||||
| Proceeds from borrowings | |||||
| Repayment of borrowings | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | |||||
| Net increase in cash and cash equivalents and restricted cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash equivalents at beginning of period | |||||
| Cash and cash equivalents and restricted cash equivalents at end of period | |||||
| Cash and cash equivalents, and restricted cash and cash equivalents at end of period | |||||
| Unrestricted cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
| Cash and cash equivalents, and restricted cash and cash equivalents at end of period | |||||
| Supplemental cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Accretion of discount associated with issuance of subsidiary equity | |||||
| Decrease in accrued and unpaid preferred stock and preferred unit dividends | |||||
| Noncash investing and financing | |||||
| Cash assumed upon acquisition of Mercury | |||||
Loading...